Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Gemeprost is a prostaglandin E1 analogue used for cervical dilation and, in combination with mifepristone, for pregnancy termination. Gemeprost is a prostaglandin E1 (PGE1) analog and antiprogestogen used for preoperative dilation of the cervix before surgical abortion.
- Mechanism
- Curator reviewed · 1 reference
As a prostaglandin analog, gemeprost binds to prostaglandin E2 and E3 receptors as an agonist to cause myometrial contractions and progressive cervical dilation via tissue sensitization to oxytocin.
- Primary indication
- Indicated for the softening and dilatation of the cervix uteri prior to transcervical, intrauterine operative procedures in the first trimester of pregnancy or facilitating therapeutic termination of pregnancy in patients in the second trimester of...Curator reviewed · 2 structured indications
- Formula / weight
- C23H38O5 · 394.552 g/mol (avg)
- Code names
- SC-37681
Resolves to
KYBOHGVERHWSSV-VNIVIJDLSA-NSMILESCCCCC(C)(C)[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCC\C=C\C(=O)OCWhat you can answer from here — as of August 01, 2025
Which drugs share a target with Gemeprost, and which of those have an active Phase 3 trial?